Clinical trial

A Phase 2 Trial of OPC-64005 for Major Depressive Disorder

NCT04244253

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-03-03

PhasePHASE2

Study timeline

Study start (actual)2020-03-03Date precision: day

Registry last updated2024-09-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderunresolved

Interventions

OPC-64005 20 mg , Once-dailyDRUG

OPC-64005 10 mg , Once-dailyDRUG

Placebo, Once-dailyDRUG

Sponsors & collaborators

Otsuka Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

TokyoJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04244253 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.